CIK 0001527753
- Non-accelerated filer
- Smaller reporting company
Personalis, Inc.
Sign in to watch- Ticker
- PSNL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275411038
- Phone
- +1 650-752-1300
- Business address
- 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
- 4 Open-market sale Chief Financial Officer sold 3,440 shares at $3.29 ($11,318)
- 4 Open-market sale General Counsel sold 1,832 shares at $3.24 ($5,936)
- 4 Open-market sale Chief Medical Officer sold 6,818 shares at $3.24 ($22,090)
- 4 Open-market sale Chief Financial Officer sold 6,818 shares at $3.24 ($22,090)
- 4 Open-market sale Chief Financial Officer sold 4,187 shares at $3.59 ($15,031)
- 4 Open-market sale Chief Medical Officer sold 421 shares at $3.59 ($1,511)
- 4 Grant or award Director acquired 10,770 shares (grant or award)
- 4 Grant or award Director acquired 10,770 shares (grant or award)
- 4 Grant or award Director acquired 10,770 shares (grant or award)
- 4 Grant or award Director acquired 10,770 shares (grant or award)
- 4 Grant or award Director acquired 10,770 shares (grant or award)
- 4 Grant or award Director acquired 10,770 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 1,286 shares at $4.86 ($6,250)
- 4 Open-market sale President and CEO sold 2,408 shares at $4.86 ($11,703)
- 4 Open-market sale General Counsel sold 664 shares at $4.86 ($3,227)
- 4 Open-market sale Chief Medical Officer sold 1,286 shares at $4.86 ($6,250)
- 4 Open-market sale General Counsel sold 5,733 shares at $5.53 ($31,703)
- 4 Option exercise President and CEO acquired 45,061 shares (option exercise)
- 4 Open-market sale President and CEO sold 64,430 shares
- 4 Grant or award President and CEO acquired 54,347 shares (grant or award)
Page 8 of 15 · 289 filings